abstract |
The invention relates to the use of an antagonist and/or inverse agonist of the CB1 receptors, preferably Rimonabant, for the preparation of drugs that can be used to increase motor neuron excitability in the cerebral cortex and/or the brain stem and/or the spinal cord, as well as to a method for increasing motor neuron excitability by administering an antagonist/inverse agonist of the CB1 receptors, and to the use of a pharmaceutical composition that contains an antagonist and/or inverse agonist of the CB1 receptors, preferably Rimonabant, to increase motor neuron excitability in the cerebral cortex and/or the brain stem and/or the spinal cord. |